Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients

Abstract

Objectives This paper reviews a 12-year experience in more than 900 patients with spasmodic dysphonia who have been treated with botulinum toxin. Study design This is a retrospective analysis of patients with adductor spasmodic dysphonia (strain-strangled voice), abductor spasmodic dysphonia (whispering voice), and adductor breathing dystonia (paradoxical vocal fold motion), all of whom have been treated with botulinum toxin injections for relief of symptom. Methods All of the patients were studied with a complete head and neck and neurologic examination; fiberoptic laryngostroboscopy; acoustic and aerodynamic measures; and a speech evaluation including the Universal spasmodic dysphonia rating scale. Some were given electromyography. All patients received botulinum toxin injections into the affected muscles under electromyographic guidance. Results The adductor patients had an average benefit of 90% of normal function lasting an average of 15.1 weeks. The abductor patients had an average benefit of 66.7% of normal function lasting an average of 10.5 weeks. Adverse effects included mild breathiness and coughing on fluids in the adductor patients, and mild stridor in a few of the abductor patients. Conclusion Botulinum toxin A injection of the laryngeal hyperfunctional muscles has been found over the past 12 years to be the treatment of choice to control the dystonic symptoms in most patients with spasmodic dysphonia.

Overview

Integrity signals

Registry

Crossref · 10.1097/00005537-199810000-00003

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Research works printed but not linked: 3

  1. Fahn S, 1988, X‐linked recessive dystonia and parkinsonism in Filipino males [abstract], Ann Neurol, 24, 179
  2. 10.1002/ana.410270203 · DOI
  3. Koufman JA, 1992, New classification of laryngeal dystonias, The Visible Voice, 1, 1

Cited by

See all 408

Metadata

Authors
Blitzer, A., Brin, M. F., & Stewart, C. F.
Affiliations
New York University (US)
Corresponding author
Blitzer, Andrew
Venue
The Laryngoscope
Publisher
Wiley
Published
1998-10
Volume
108
Issue
10
Pages
1435-1441
ISSN
  • 0023-852X (ISSN-L)
  • 1531-4995
OpenAlex
W2002504714
Cited by
391
References
34
Citations by year
2026: 15 · 2025: 15 · 2024: 8 · 2023: 8 · 2022: 18 · 2021: 17 · 2020: 17 · 2019: 9 · 2018: 20 · 2017: 17 · 2016: 19 · 2015: 10 · 2014: 22 · 2013: 8 · 2012: 12
FWCI
4.70
Type
journal article
Language
en
Open access
closed
Locations
  • The Laryngoscope (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
  • Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory and Cough-Related Research
Keywords
spasmodic dysphonia, laryngeal dystonia, botulinum toxin type A, adductor spasmodic dysphonia, abductor spasmodic dysphonia, treatment outcomes, adverse effects, stridor, breathiness
MeSH terms
Adult, Electromyography, Female, Humans, Male, Neuromuscular Agents, Retrospective Studies, Voice Disorders, Treatment Outcome, Botulinum Toxins, Type A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients. https://app.cochat.ai/papers/10.1097/00005537-199810000-00003
The paper
Blitzer, A., Brin, M. F., & Stewart, C. F. (1998). Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients. The Laryngoscope. https://doi.org/10.1097/00005537-199810000-00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.